Editorial Comment to Loss of phosphatase and tensin homolog expression in castration‐sensitive prostate cancer predicts outcomes in men after prostatectomy
Fuente:
Wiley Open Access
Guardado en:
| Autor principal: | Masaki Shiota |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2024
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Loss of phosphatase and tensin homolog expression castration‐sensitive prostate cancer predicts outcomes in men after prostatectomy
por: Yoshinori Yanai, et al.
Publicado: (2024)
por: Yoshinori Yanai, et al.
Publicado: (2024)
Editorial Comment to Survival beyond cabazitaxel for metastatic castration‐resistant prostate cancer
por: Yoshiyuki Yamamoto, et al.
Publicado: (2024)
por: Yoshiyuki Yamamoto, et al.
Publicado: (2024)
Risk assessment of late biochemical recurrence after radical prostatectomy: Usefulness of ultra‐sensitive prostate‐specific antigen measurement
por: Norihiko Kawamura, et al.
Publicado: (2024)
por: Norihiko Kawamura, et al.
Publicado: (2024)
Editorial Comment on “Initial outcomes and surgical techniques of prostatic urethral lift for benign prostatic hyperplasia in Japan”
por: Takafumi Yagisawa, et al.
Publicado: (2024)
por: Takafumi Yagisawa, et al.
Publicado: (2024)
Clinical features and oncological outcomes of bladder cancer microsatellite instability
por: Shohei Nagakawa, et al.
Publicado: (2024)
por: Shohei Nagakawa, et al.
Publicado: (2024)
Editorial Comment to “Can the Briganti 2019 nomogram be modified to predict lymph node metastasis risk in patients with prostate cancer detected with in‐bore biopsy?”
por: Yoh Matsuoka
Publicado: (2024)
por: Yoh Matsuoka
Publicado: (2024)
Editorial Comment on “The role of lipidic balance on erectile dysfunction in prostate cancer patients undergoing robotic surgery”
por: Marcello Della Corte, et al.
Publicado: (2024)
por: Marcello Della Corte, et al.
Publicado: (2024)
Dose compliance of estramustine phosphate in neoadjuvant chemohormonal therapy combined with degarelix acetate predicts the biochemical recurrence in patients with very high‐risk prostate cancer who underwent robot‐assisted radical prostatectomy
por: Takanari Kambe, et al.
Publicado: (2024)
por: Takanari Kambe, et al.
Publicado: (2024)
Editorial Comment to “Causal relationship between folic acid and prostate cancer risk: Insights from Mendelian randomization analysis”
por: Yozo Mitsui, et al.
Publicado: (2024)
por: Yozo Mitsui, et al.
Publicado: (2024)
Editorial Comment on “Association between antibiotic use and subsequent risk of prostate cancer: A retrospective cohort study in South Korea”
por: Koji Hatano
Publicado: (2024)
por: Koji Hatano
Publicado: (2024)
Editorial Comment on “Efficacy and safety of prostatic urethral lift according to preoperative urinary retention and prostate volume: Japanese real‐world multicenter data”
por: Yuki Kyoda, et al.
Publicado: (2024)
por: Yuki Kyoda, et al.
Publicado: (2024)
Editorial Comment to Histological parameters and stromal desmoplastic status affecting accurate diagnosis of extraprostatic extension of prostate cancer using multi‐parametric magnetic resonance imaging
por: Sunao Shoji
Publicado: (2024)
por: Sunao Shoji
Publicado: (2024)
Effects of modifying hinotori™ surgical robot system on perioperative outcome of robot‐assisted radical prostatectomy
por: Jun Teishima, et al.
Publicado: (2024)
por: Jun Teishima, et al.
Publicado: (2024)
Utility of positive core number on MRI‐ultrasound fusion targeted biopsy in combination with PI‐RADS scores for predicting unexpected extracapsular extension of clinically localized prostate cancer
por: Masaki Kobayashi, et al.
Publicado: (2024)
por: Masaki Kobayashi, et al.
Publicado: (2024)
The effect of incontinence after radical prostatectomy on quality of life and frailty
por: Aysenur Ata, et al.
Publicado: (2024)
por: Aysenur Ata, et al.
Publicado: (2024)
Predictive ability of lesion localization using real‐time three‐dimensional magnetic resonance imaging/ultrasound fusion prostate biopsy in robot‐assisted laparoscopic prostatectomy
por: Yukari Bando, et al.
Publicado: (2025)
por: Yukari Bando, et al.
Publicado: (2025)
Decision regret after curative treatment and its association with the decision‐making process and quality of life for prostate cancer patients
por: Miho Sato, et al.
Publicado: (2024)
por: Miho Sato, et al.
Publicado: (2024)
Changes in the treatment landscape of metastatic hormone‐sensitive prostate cancer following approval of upfront androgen receptor signaling inhibitors: A multicenter study
por: Fumihiko Urabe, et al.
Publicado: (2024)
por: Fumihiko Urabe, et al.
Publicado: (2024)
Editorial Comment on Prostate cancer and liquid biopsies: Clinical applications and challenges
por: Yusuke Goto
Publicado: (2024)
por: Yusuke Goto
Publicado: (2024)
Early recovery of urinary continence after robot‐assisted radical prostatectomy is associated with membranous urethra and neurovascular bundle preservation
por: Satoshi Ando, et al.
Publicado: (2024)
por: Satoshi Ando, et al.
Publicado: (2024)
Validation study on the 2 mm diameter cutoff in lymph node‐positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real‐world data analysis from a Japanese cohort
por: Masashi Kato, et al.
Publicado: (2024)
por: Masashi Kato, et al.
Publicado: (2024)
Can the Briganti 2019 nomogram be modified to predict lymph node metastasis risk in patients with prostate cancer detected with in‐bore biopsy?
por: Serdar Madendere, et al.
Publicado: (2024)
por: Serdar Madendere, et al.
Publicado: (2024)
Japanese clinical practice guidelines for prostate cancer 2023
por: Yasuo Kohjimoto, et al.
Publicado: (2024)
por: Yasuo Kohjimoto, et al.
Publicado: (2024)
Downregulation of miR ‐211 expression in the blood plasma of infertile men compared to the fertile controls
por: Nasim Naeimi, et al.
Publicado: (2024)
por: Nasim Naeimi, et al.
Publicado: (2024)
Editorial Comment on Longitudinal mortality risks and kidney functional outcomes in Japanese living kidney donors
por: Masayoshi Okumi
Publicado: (2024)
por: Masayoshi Okumi
Publicado: (2024)
Development and validation of a model to predict the outcomes of radical cystectomy in patients with bladder cancer
por: Wataru Fukuokaya, et al.
Publicado: (2024)
por: Wataru Fukuokaya, et al.
Publicado: (2024)
A 3‐month mark to urinary continence, after robotic radical prostatectomy—Is it possible?
por: Tiago Santos, et al.
Publicado: (2024)
por: Tiago Santos, et al.
Publicado: (2024)
Trends in drug treatment of benign prostatic hyperplasia in Japan based on the National Database Open Data
por: Kenichi Sasaki, et al.
Publicado: (2024)
por: Kenichi Sasaki, et al.
Publicado: (2024)
How widespread is active surveillance of early‐stage prostate cancer in Japan? Multicenter questionnaire survey on the status of active surveillance of early‐stage prostate cancer in Japan
por: Takuma Kato, et al.
Publicado: (2024)
por: Takuma Kato, et al.
Publicado: (2024)
Editorial Comment on “Clinicopathological Characteristics of Upper Tract Urothelial Cancer With Loss of Immunohistochemical Expression of Mismatch Repair Proteins”
por: Takashi Kobayashi
Publicado: (2025)
por: Takashi Kobayashi
Publicado: (2025)
Postoperative infections after robotic‐assisted radical prostatectomy in a single large institution: Effect of type and duration of prophylactic antibiotic administration
por: Masao Mitsui, et al.
Publicado: (2024)
por: Masao Mitsui, et al.
Publicado: (2024)
Editorial Comment on Anatomical outcomes and complications of sacrocolpopexy using surelift uplift mesh: A multicentric observational study
por: Elisabetta Costantini, et al.
Publicado: (2024)
por: Elisabetta Costantini, et al.
Publicado: (2024)
Editorial Comment to Clinical characteristics and survival outcomes of elderly patients with de novo metastatic germ cell tumors
por: Takeshi Kishida
Publicado: (2024)
por: Takeshi Kishida
Publicado: (2024)
Editorial Comment to The DDD score outperforms the RENAL score in predicting high‐grade renal cell carcinoma
por: Hiroki Ishihara, et al.
Publicado: (2024)
por: Hiroki Ishihara, et al.
Publicado: (2024)
Moving toward improved immune checkpoint immunotherapy for advanced prostate cancer
por: Marco A. De Velasco, et al.
Publicado: (2024)
por: Marco A. De Velasco, et al.
Publicado: (2024)
Efficacy of docetaxel addition to next‐generation androgen receptor‐axis‐targeted therapies and androgen deprivation therapy in metastatic hormone‐sensitive prostate cancer: A tumor volume‐specific analysis
por: Wei Chen, et al.
Publicado: (2024)
por: Wei Chen, et al.
Publicado: (2024)
Editorial Comment to “Stone at the same location for 2 months predicts impacted stones and stone‐free status after shock wave lithotripsy for ureteral stones: A Funabashi clinic expert study”
por: Ryoji Takazawa
Publicado: (2025)
por: Ryoji Takazawa
Publicado: (2025)
Editorial Comment on Real‐world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan
por: Hiroki Ishihara, et al.
Publicado: (2024)
por: Hiroki Ishihara, et al.
Publicado: (2024)
Novel image‐guided marker aimed at organ‐preserving therapies for prostate cancer
por: Koji Okihara, et al.
Publicado: (2024)
por: Koji Okihara, et al.
Publicado: (2024)
Comparison of oncological and functional results of robotic and open perineal radical prostatectomy
por: Yunus Çolakoğlu, et al.
Publicado: (2024)
por: Yunus Çolakoğlu, et al.
Publicado: (2024)
Ejemplares similares
-
Loss of phosphatase and tensin homolog expression castration‐sensitive prostate cancer predicts outcomes in men after prostatectomy
por: Yoshinori Yanai, et al.
Publicado: (2024) -
Editorial Comment to Survival beyond cabazitaxel for metastatic castration‐resistant prostate cancer
por: Yoshiyuki Yamamoto, et al.
Publicado: (2024) -
Risk assessment of late biochemical recurrence after radical prostatectomy: Usefulness of ultra‐sensitive prostate‐specific antigen measurement
por: Norihiko Kawamura, et al.
Publicado: (2024) -
Editorial Comment on “Initial outcomes and surgical techniques of prostatic urethral lift for benign prostatic hyperplasia in Japan”
por: Takafumi Yagisawa, et al.
Publicado: (2024) -
Clinical features and oncological outcomes of bladder cancer microsatellite instability
por: Shohei Nagakawa, et al.
Publicado: (2024)